A detailed history of Arizona State Retirement System transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 18,472 shares of XENE stock, worth $718,560. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,472
Previous 17,949 2.91%
Holding current value
$718,560
Previous $699,000 3.86%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$36.12 - $43.96 $18,890 - $22,991
523 Added 2.91%
18,472 $726,000
Q2 2024

Aug 05, 2024

BUY
$36.25 - $43.75 $24,940 - $30,100
688 Added 3.99%
17,949 $699,000
Q1 2024

May 07, 2024

SELL
$42.66 - $50.04 $12,414 - $14,561
-291 Reduced 1.66%
17,261 $743,000
Q4 2023

Jan 24, 2024

BUY
$28.7 - $46.46 $88,223 - $142,818
3,074 Added 21.23%
17,552 $808,000
Q3 2023

Nov 06, 2023

BUY
$34.16 - $39.73 $10,692 - $12,435
313 Added 2.21%
14,478 $494,000
Q2 2023

Aug 01, 2023

BUY
$34.84 - $43.54 $19,998 - $24,991
574 Added 4.22%
14,165 $545,000
Q1 2023

Apr 27, 2023

BUY
$33.46 - $40.35 $13,852 - $16,704
414 Added 3.14%
13,591 $486,000
Q4 2022

Feb 07, 2023

BUY
$33.06 - $39.43 $24,795 - $29,572
750 Added 6.04%
13,177 $519,000
Q3 2022

Nov 07, 2022

BUY
$30.79 - $39.82 $59,424 - $76,852
1,930 Added 18.39%
12,427 $449,000
Q2 2022

Jul 28, 2022

SELL
$25.44 - $35.16 $16,764 - $23,170
-659 Reduced 5.91%
10,497 $319,000
Q1 2022

May 04, 2022

BUY
$25.09 - $33.13 $11,967 - $15,803
477 Added 4.47%
11,156 $341,000
Q4 2021

Feb 04, 2022

BUY
$15.6 - $35.4 $166,592 - $378,036
10,679 New
10,679 $334,000

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.42B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.